Valneva SE (VALN) Exchange Rate Effect (2021 - 2026)
Valneva SE (VALN) posted Exchange Rate Effect of $400395.0 for Q1 2026, up 6.82% sequentially from $374822.0 in Q4 2025, and up 164.52% YoY from $151368.8 in Q1 2025.
Valneva SE (VALN) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Valneva SE has reported Exchange Rate Effect for 6 years, with the latest figure at $400395.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 164.52% year-over-year to $400395.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 276.12% YoY) and the FY2025 annual result came in at -$4.0 million, down 301.74% from the prior year.
- Exchange Rate Effect grew to $400395.0 in Q1 2026 per VALN's latest filing, from $374822.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $633.2 million in Q3 2023 and troughed at -$633.4 million in Q2 2023.
- A 5-year average of -$160233.8 and a median of -$49100.3 in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 58979.99% in 2023, down 69281.37% in 2023.
- Over 5 years, Exchange Rate Effect stood at -$2.7 million in 2022, then surged by 104.43% to $119429.3 in 2023, then surged by 1969.56% to $2.5 million in 2024, then plunged by 84.84% to $374822.0 in 2025, then gained by 6.82% to $400395.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $400395.0, $374822.0, and -$49100.3 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | 180,166.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 180,166.09 |
| Jun 30, 2026 | 180,166.09 |
| Mar 31, 2026 | 400,395.01 |
| Mar 31, 2026 | 400,395.01 |
| Dec 31, 2025 | 374,822.01 |
| Dec 31, 2025 | 374,822.01 |
| Sep 30, 2025 | -49,100.31 |
| Sep 30, 2025 | -49,100.31 |
| Jun 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Mar 31, 2025 | -620,611.82 |
| Mar 31, 2025 | -620,611.82 |
| Dec 31, 2024 | 2.47 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | 903,508.68 |
| Jun 30, 2024 | 903,508.68 |
| Mar 31, 2024 | -286,799.51 |
| Mar 31, 2024 | -286,799.51 |